Interleukin-1 receptor antagonist (IL-1ra) is unable to reverse cachexia in rats bearing an ascites hepatoma (Yoshida AH-130)
- 1 August 1995
- journal article
- Published by Elsevier in Cancer Letters
- Vol. 95 (1-2) , 33-38
- https://doi.org/10.1016/0304-3835(95)03858-t
Abstract
No abstract availableThis publication has 26 references indexed in Scilit:
- Tumor necrosis factor-alpha mediates changes in tissue protein turnover in a rat cancer cachexia model.Journal of Clinical Investigation, 1993
- Cancer Cachexia, Malnutrition, and Tissue Protein Turnover in Experimental AnimalsArchives of Biochemistry and Biophysics, 1993
- Humoral mediation for cachexia in tumour-bearing ratsBritish Journal of Cancer, 1993
- The history, properties, and biological effects of cachectinBiochemistry, 1988
- EVIDENCE FOR TUMOUR NECROSIS FACTOR/CACHECTIN PRODUCTION IN CANCERThe Lancet, 1987
- Regulation of protein turnover versus growth state: Ascites hepatoma as a model for studies both in the animal and in vitroArchives of Biochemistry and Biophysics, 1987
- Secretory products of macrophages.Journal of Clinical Investigation, 1987
- Early development of protein metabolic perturbations in the liver and skeletal muscle of tumour-bearing rats. A model system for cancer cachexiaBiochemical Journal, 1987
- Metabolic Approaches to Cancer CachexiaAnnual Review of Nutrition, 1982
- Pathogenesis of cachexia in cancer.A review and a hypothesisCancer, 1972